Khuri FR - Search Results

1

Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma.

Jiang N, Wang D, Hu Z, Shin HJ, Qian G, Rahman MA, Zhang H, Amin AR, Nannapaneni S, Wang X, Chen Z, Garcia G, MacBeath G, Shin DM, Khuri FR, Ma J, Chen ZG, Saba NF. Jiang N, et al. Among authors: khuri fr. Mol Cancer Ther. 2014 Jul;13(7):1826-36. doi: 10.1158/1535-7163.MCT-13-1093. Epub 2014 Apr 18. Mol Cancer Ther. 2014. PMID: 24748655 Free PMC article.

2

Emerging drugs for head and neck cancer.

Rhee JC, Khuri FR, Shin DM. Rhee JC, et al. Among authors: khuri fr. Expert Opin Emerg Drugs. 2004 May;9(1):91-104. doi: 10.1517/eoed.9.1.91.32953. Expert Opin Emerg Drugs. 2004. PMID: 15155138 Review.

3

Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancer.

Saba NF, Khuri FR, Shin DM. Saba NF, et al. Among authors: khuri fr. Oncology (Williston Park). 2006 Feb;20(2):153-61; discussion 162, 166, 169 passim. Oncology (Williston Park). 2006. PMID: 16562649 Review.

4

Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.

Zhang X, Chen ZG, Khuri FR, Shin DM. Zhang X, et al. Among authors: khuri fr. Head Neck. 2007 Apr;29(4):351-61. doi: 10.1002/hed.20525. Head Neck. 2007. PMID: 17163463

5

Moving toward bioadjuvant approaches to head and neck cancer prevention.

Saba NF, Hammond A, Shin DM, Khuri FR. Saba NF, et al. Among authors: khuri fr. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S132-5. doi: 10.1016/j.ijrobp.2007.05.041. Int J Radiat Oncol Biol Phys. 2007. PMID: 17848282 Review.

6

Targeting angiogenesis in head and neck cancer.

Saba NF, Shin DM, Khuri FR. Saba NF, et al. Among authors: khuri fr. Curr Cancer Drug Targets. 2007 Nov;7(7):643-9. doi: 10.2174/156800907782418356. Curr Cancer Drug Targets. 2007. PMID: 18045069 Review.

7

Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.

Zhang X, Zhang H, Tighiouart M, Lee JE, Shin HJ, Khuri FR, Yang CS, Chen Z', Shin DM. Zhang X, et al. Among authors: khuri fr. Int J Cancer. 2008 Sep 1;123(5):1005-14. doi: 10.1002/ijc.23585. Int J Cancer. 2008. PMID: 18546267 Free PMC article.

8

Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents.

Saba NF, Khuri FR. Saba NF, et al. Among authors: khuri fr. Curr Opin Oncol. 2009 May;21(3):232-7. doi: 10.1097/cco.0b013e32832a56b3. Curr Opin Oncol. 2009. PMID: 19370807 Review.

9

Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.

Amin AR, Khuri FR, Chen ZG, Shin DM. Amin AR, et al. Among authors: khuri fr. Cancer Prev Res (Phila). 2009 Jun;2(6):538-45. doi: 10.1158/1940-6207.CAPR-09-0063. Epub 2009 May 26. Cancer Prev Res (Phila). 2009. PMID: 19470788 Free PMC article.

10

Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Saba NF, Choi M, Muller S, Shin HJ, Tighiouart M, Papadimitrakopoulou VA, El-Naggar AK, Khuri FR, Chen ZG, Shin DM. Saba NF, et al. Among authors: khuri fr. Cancer Prev Res (Phila). 2009 Sep;2(9):823-9. doi: 10.1158/1940-6207.CAPR-09-0077. Epub 2009 Sep 8. Cancer Prev Res (Phila). 2009. PMID: 19737986 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

479 results

Search Page